Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer

Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer

Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) have a poor prognosis, with a significant risk of progression or death despite multimodal treatment with surgery, chemotherapy, and radiotherapy. Immune checkpoint inhibitors targeting the programmed death receptor-1 (PD1)...

Full description

Bibliographic Details
Main Authors: Yuan James Rao, Joseph F. Goodman, Faysal Haroun, Julie E. Bauman
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
immunotherapy
immune checkpoint inhibitors
head and neck squamous cell carcinoma
radiation
surgery
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/15/3/672

Similar Items

Similar Items